Clover Health (NASDAQ:CLOV) Continue to trade Higher As Insiders Buying Shares
Clover Health (NASDAQ:CLOV) Continue to Push Higher As Insiders Buying More Shares.
“Chelsea Clinton has served as a member of Clover’s board of directors since February 2017. Since March 2013, Ms. Clinton has served as Vice-Chair of the Clinton Foundation, where her work emphasizes improving global and domestic health, creating service opportunities, and empowering the next generation of leaders.” Recently, Chelsea Clinton bought the CLOV shares, which start showing some positive sentiments towards the stock price. Clover Health is in great shape from the financial perspective as they continue to beat the revenue estimate and continue to grow year over year.
Clover Health expects its Total revenues to be in the range of $3.0 billion to $3.4 billion. This includes projected MA revenue of $1.0 billion to $1.1 billion and Direct Contracting revenue of $2.0 billion to $2.3 billion in 2022.
|2022-03-04||2022-03-03||4||Clinton Chelsea||CLOV||Class A Common Stock||P – Purchase||2.5253||100,000||253||100,000|
SIGN UP TO THIS SITE FOR FREE – Receive Daily Short Squeeze Email Updates
Sponsered: CapitalOne Silver Credit Card is giving a $200 sign-up bonus after you spend $500 in the first 3 months. This card is the most recommended for everyday spending, Earn unlimited 1.5% cash back on every purchase, with no annual fees. If you think you will spend $500 in 3 months, this might be a great card for you to start, and get that $200 sign-up bonus.